AU3236293A - Composition and treatment with biologically active peptides and chelating agents - Google Patents

Composition and treatment with biologically active peptides and chelating agents

Info

Publication number
AU3236293A
AU3236293A AU32362/93A AU3236293A AU3236293A AU 3236293 A AU3236293 A AU 3236293A AU 32362/93 A AU32362/93 A AU 32362/93A AU 3236293 A AU3236293 A AU 3236293A AU 3236293 A AU3236293 A AU 3236293A
Authority
AU
Australia
Prior art keywords
peptide
ala
amino acids
basic
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32362/93A
Other languages
English (en)
Inventor
Barry Berkowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Magainin Pharmaceuticals Inc
Original Assignee
Magainin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magainin Pharmaceuticals Inc filed Critical Magainin Pharmaceuticals Inc
Publication of AU3236293A publication Critical patent/AU3236293A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU32362/93A 1991-12-09 1992-12-03 Composition and treatment with biologically active peptides and chelating agents Abandoned AU3236293A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80362991A 1991-12-09 1991-12-09
US803629 1991-12-09

Publications (1)

Publication Number Publication Date
AU3236293A true AU3236293A (en) 1993-07-19

Family

ID=25187054

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32362/93A Abandoned AU3236293A (en) 1991-12-09 1992-12-03 Composition and treatment with biologically active peptides and chelating agents

Country Status (5)

Country Link
EP (1) EP0661988A1 (ja)
JP (1) JPH07501820A (ja)
AU (1) AU3236293A (ja)
CA (1) CA2125494A1 (ja)
WO (1) WO1993011783A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US6057291A (en) 1995-06-02 2000-05-02 University Of British Columbia Antimicrobial cationic peptides
JP3860838B2 (ja) 1995-08-23 2006-12-20 ユニバーシティー オブ ブリティッシュ コロンビア 抗微生物性陽イオン性ペプチドおよびそのスクリーニング方法
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US6010876A (en) * 1996-11-06 2000-01-04 The Regents Of The University Of California Clavanins
US6040293A (en) * 1996-11-06 2000-03-21 The Regents Of The University Of California Clavanins
WO2005074968A2 (en) * 2004-02-10 2005-08-18 Universiteit Maastricht Medical use of basic peptides
GB0415985D0 (en) * 2004-07-19 2004-08-18 Taylor Russell Methods of manufacture and applications of a chelating compounds or substances that when used as a treatment for burns will assist in the growth
WO2009094634A1 (en) 2008-01-24 2009-07-30 Esperance Pharmaceuticals Lytic domain fusion constructs and methods of making and using same
PT105332A (pt) * 2010-10-12 2012-04-12 Cev Biotecnologia Das Plantas S A Agentes para utilização com antimicrobianos
AU2011315525B2 (en) * 2010-10-12 2016-05-12 Consumo Em Verde - Biotecnologia Das Plantas, S.A. Antimicrobial protein
AU2013337926B2 (en) 2012-10-30 2017-12-21 Esperance Pharmaceuticals, Inc. Antibody/drug conjugates and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
US5073542A (en) * 1989-06-07 1991-12-17 Magainin Sciences Inc. CPF peptide compositions and their use in inhibiting growth of target cells or a virus
US5559096A (en) * 1991-04-15 1996-09-24 Applied Microbiology, Inc. Pharmaceutical compositions against gastric disorders

Also Published As

Publication number Publication date
WO1993011783A1 (en) 1993-06-24
EP0661988A1 (en) 1995-07-12
JPH07501820A (ja) 1995-02-23
CA2125494A1 (en) 1993-06-24
EP0661988A4 (en) 1995-02-10

Similar Documents

Publication Publication Date Title
US5045531A (en) Wound treatment employing biologically active ion channel forming peptides and proteins
US5221664A (en) Composition and treatment with biologically active peptides and toxic cations
AU674525B2 (en) Biologically active peptides having N-terminal substitutions
AU3236293A (en) Composition and treatment with biologically active peptides and chelating agents
EP0469036A4 (en) Composition and treatment with biologically active peptides and antibiotic
US5208220A (en) Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
US5654274A (en) Biologically active peptides having N-terminal substitutions
WO1991012015A1 (en) Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
WO1994012206A1 (en) Treatment of dermatological malignancies with biologically active peptides
EP0590044A1 (en) Composition and treatment with biologically active peptides having c-terminal substitutions
WO1994005313A1 (en) Treatment of gynecological malignancies with biologically active peptides
AU641129B2 (en) Composition and treatment with biologically active peptides and certain anions
AU693518B2 (en) Ion-channel forming amphiphilic peptides having n-terminal modifications
WO1991016066A1 (en) Composition and treatment with biologically active peptides and toxic cations
WO1994019369A1 (en) Treatment of cancerous growths with biologically active peptides and protease inhibitors
EP0533795A4 (en) Composition of and treatment with biologically active peptides having d-amino acid residues
WO1992000090A1 (en) Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
WO1991016918A1 (en) Composition and treatment with biologically active peptides and anti-parasitic agents or anti-fungal agents
WO1993007892A1 (en) Composition and treatment with biologically active peptides and antibiotic